PONTIFAX
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
PONTIFAX
Social Links:
Industry:
Biotechnology Medical Device Pharmaceutical Venture Capital
Founded:
2004-01-01
Status:
Active
Contact:
+972 9 9725617
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome Mobile Non Scaleable Content Organization Schema Sitelinks Search Box
Similar Organizations
360Guanxi
360Guanxi is an integrated media company that caters to Chinese chemical, pharmaceutical, and life science industries.
Corundum Open Innovations
Corundum Open Innovations is a venture capital firm that invests in ICT and life sciences companies and funds.
Echo Health Ventures
Echo Health Ventures is a venture capital firm that focuses on investing in health care companies.
Lilly Asia Ventures
Lilly Asian Ventures is an investment firm that invests in promising life science companies.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Sequoia Capital India
Sequoia Capital India is a venture capital firm that invests in consumer, technology, and healthcare.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-06-11 | Adcytherix | Pontifax investment in Seed Round - Adcytherix | 30 M EUR |
| 2024-05-29 | ADCendo | Pontifax investment in Series A - ADCendo | 16 M EUR |
| 2024-04-11 | Eliem Therapeutics | Pontifax investment in Post-IPO Equity - Eliem Therapeutics | 120 M USD |
| 2024-01-24 | LB Pharmaceuticals | Pontifax investment in Series C - LB Pharmaceuticals | 75 M USD |
| 2023-10-11 | AgomAb Therapeutics | Pontifax investment in Series C - AgomAb Therapeutics | 94.9 M EUR |
| 2023-08-17 | Abcuro | Pontifax investment in Series B - Abcuro | 155 M USD |
| 2023-04-04 | ADCendo | Pontifax investment in Series A - ADCendo | 31 M EUR |
| 2023-01-06 | Amolyt Pharma | Pontifax investment in Series C - Amolyt Pharma | 130 M EUR |
| 2022-12-20 | Graviton Bioscience | Pontifax investment in Venture Round - Graviton Bioscience | 39.82 M USD |
| 2022-03-16 | Precirix | Pontifax investment in Series B - Precirix | 80 M EUR |
More informations about "Pontifax"
About Us - Pontifax Venture Capital
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with $1.2 billion under management. We seek transformative, cutting-edge life sciences technologies at all …See details»
Pontifax - Crunchbase Investor Profile & Investments
Pontifax invests in early to late-stage biotechnology and healthcare companies, focusing on therapeutics. Their investment strategy spans North America and Europe, with key locations in New York, Ghent, and Newton. Learn More. …See details»
Team - Pontifax Venture Capital
Prior to joining Pontifax, Momi was a General Partner in Viola Credit, a leading Israeli venture debt fund, which initiated more than 100 debt transactions in mid to late-stage technology companies in various sectors. Momi served as a …See details»
Pontifax - Investments, Portfolio & Company Exits - Crunchbase
Pontifax 's most notable exits include Keros Therapeutics, Eliem Therapeutics, and CathWorks. Which industries has this organization had the most exits in? Show . Keros Therapeutics …See details»
List of top Pontifax Portfolio Companies - Crunchbase
Aug 26, 2011 Pontifax is a venture capital firm that finances pharmaceutical and life sciences companies. This list of organizations invested in by Pontifax provides data on their funding …See details»
Pontifax Venture Capital - The Org
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $350 million under management. They seek transformative, cutting-edge life sciences technologies at all …See details»
Pontifax Venture Capital - LinkedIn
Pontifax Venture Capital | 1,087 followers on LinkedIn. Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $1.2 billion under management. We seek transformative ...See details»
Pontifax - Israeli VC and Private Equity | Startup Nation Finder
Jan 1, 2018 Pontifax is a healthcare-focused venture capital firm seeking transformative, cutting-edge life-sciences technologies in all therapeutic areas and development stages. Its portfolio …See details»
Pontifax Company Profile | Management and Employees List
Pontifax Profile and History . Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $750 million under management. We seek transformative, cutting-edge life …See details»
Portfolio - Pontifax Venture Capital
LB’s approach is to create a research-focused organization dedicated to generating novel intellectual property around improved versions of these former best-selling drugs. Field: BioPharma. Status: Private. Levation. Levation is …See details»
Pontifax - Investor Profile, Portfolio & Team - Tracxn
Pontifax - VC firm investing in early & growth stage life sciences companies in Israel. Portfolio of 93 companies. 145 investors have invested with Pontifax. Team has 8 partners.See details»
Pontifax - Private Equity List
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with $1.2 billion under management. We seek transformative, cutting-edge life sciences technologies at all …See details»
Pontifax | StartupHub.ai
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $350 million under management. We seek transformative, cutting-edge life sciences technologies at all …See details»
Pontifax - Funding, Financials, Valuation & Investors - Crunchbase
Pontifax has raised a total of $599.2M across 4 funds, their latest being Pontifax Medison Finance (Israel) L.P. This fund was announced on Apr 8, 2020 and raised a total of . obfuscated. …See details»
PE Magnates Take Pontifax to First Close on New Breed of Agtech …
Erlanger and Belldegrun decided early on to partner with Pontifax, a global life sciences venture capital investor based in Israel. Belldegrun is Israel-born with deep roots in the country, and …See details»
Pontifax AgTech closes latest fund at $302m - AgFunderNews
Oct 9, 2020 Pontifax AgTech has closed its newest fund with $302 million raised, making it one of the world’s largest agrifood-dedicated investment vehicles to date.. The Los Angeles-based …See details»
Tomer Kariv - Founder and CEO @ Pontifax - Crunchbase
Tomer Kariv is the co-founder and Chief Executive Officer of Pontifax, a group of Israeli based life sciences venture funds focusing on investments in development stage bio-pharmaceutical and …See details»
Pontifax — 100 Investments, 26 Exits, 66 Portfolio companies — …
Pontifax appeared to be the VC, which was created in 2004. The main department of described VC is located in the Herzliya. ... This organization was formed by Ran Nussbaum, Tomer …See details»
Pontifax - Contacts, Employees, Board Members, Advisors & Alumni
Pontifax has 4 current employee profiles, including Partner Momi Karako. Momi Karako Partner. Ohad Hammer Partner. Tomer Kariv Founder and CEO. Ran Nussbaum Co-Founder, …See details»